Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Antibodies to deamidated gliadin present a new tool in the diagnosis of celiac disease (CD). In children, the ELISA for the determination of IgG antibodies to (deamidated) gliadin-analogous fusion peptides (GAF3X) has a superior performance compared to the ELISA for the determination of antibodies against native gliadin and is comparable to assays for IgA antibodies against tissue transglutaminase (IgA-anti-tTG). The combined investigation of IgG antibodies to GAF3X (IgG-anti-GAF3X) and IgA-anti-tTG significantly increases the fraction of children definitely identified as either CD or non-CD patients. The new IgG-anti-GAF3X ELISA was also able to detect CD in three cases of IgA deficiency and in two cases of latent CD and was also useful in the diagnosis of children younger than 2 years of age.

Original publication

DOI

10.1111/j.1749-6632.2009.04638.x

Type

Journal article

Journal

Ann N Y Acad Sci

Publication Date

09/2009

Volume

1173

Pages

28 - 35

Keywords

Adolescent, Antibodies, Autoantibodies, Celiac Disease, Child, Child, Preschool, Enzyme-Linked Immunosorbent Assay, Gliadin, Humans, Immunoglobulin A, Immunoglobulin G, Infant, Oligopeptides, Reproducibility of Results, Retrospective Studies, Sensitivity and Specificity, Transglutaminases